Mezilamine, a new dopamine antagonist, blocks presynaptic but stimulates postsynaptic alpha-adrenoceptors

Eur J Pharmacol. 1979 Oct 15;58(4):359-67. doi: 10.1016/0014-2999(79)90306-6.

G Le Fur, J Mizoule, J Rataud, A Uzan

PMID: 41723 DOI: 10.1016/0014-2999(79)90306-6

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-119615

Mezilamine

Antidopaminergic Agent

Adrenergic Receptor

Neurological Disease; Endocrinology

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us